FDA Drug Application (050662) for BIAXIN by ABBVIE

Back to FDA Applications sponsored by ABBVIE

Application Number050662
Product Number001
FormTABLET;ORAL
Dosage250MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameBIAXIN
Active IngredientCLARITHROMYCIN

Active IngredientCount
List of drugs with Active Ingredient CLARITHROMYCIN6


Back to FDA Applications sponsored by ABBVIE